Skip to main content
Premium Trial:

Request an Annual Quote

The Race to be a Winner

James Watson's Double Helix, his account of the discovery of the structure of DNA, was first published in 1968, and the Guardian's Tim Radford takes a look back at it. "I have now read the book four or five times … and it remains startling, and in unexpected ways, startlingly good," Radford writes. He notes that neither Francis Crick nor Maurice Wilkins wanted the book to be published, and adds that while the passage of time has smoothed over some of the objections, "the passages about Rosalind Franklin remain as cruel as ever."

"But it remains a compelling book: compelling precisely because of some of the things that caused offence at the time," he says. "It presents science as a messy, confused but collegiate enterprise in which any advance is dependent on other people's achievements, but that nevertheless rewards only winners; and it presents Crick and Watson as two people who set out to be winners."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.